Inactive Instrument

Insiders Gene Biotherapeutics, Inc. Other OTC

Equities

Gene Biotherapeutics, Inc. Announces Resignation of Murray H. Hutchison from the Board	21-07-28	CI
Gene Biotherapeutics, Inc. Announces Management Changes	20-05-28	CI
Gene Biotherapeutics, Inc. Appoints James L. Grainer as Chief Financial Officer	20-05-28	CI
Gene Biotherapeutics Inc. Announces Retirement of Gerald J. Lewis from its Board of Directors	19-03-20	CI
Taxus Cardium Pharmaceuticals Group, Inc. Announces Board Retirements	16-12-14	CI
Dennis Mulroy Resigns as Chief Financial Officer of Taxus Cardium Pharmaceuticals Group Inc on April 3, 2015	15-04-03	CI
TaxuCardium Pharmaceuticals Group Inc. Announces Election of New Directors	15-01-15	CI
Cardium Therapeutics, Inc. has Changed its Name to Taxus Cardium Pharmaceuticals Group Inc	14-03-17	CI
Cardium Therapeutics Inc. Announces Medical Advisory Board to Support Excellagen Advanced Wound Care Product	12-09-20	CI

No results for this search